Indisulam

DB06370InvestigationalSmall molecule

Investigated for use/treatment in lung cancer.

Mechanism: E7070 is a novel sulfonamide antitumoragent that exhibits potent antitumoractivity in vitro and in vivo. This compound affects cell cycleprogression in human tumor cells
Curator reviewed
Primary indication: Investigated for use/treatment in lung cancer.Curator reviewed
Formula / weight: C₁₄H₁₂ClN₃O₄S₂ · 385.846 g/mol (avg)
Code names: E-7070

Resolves to

Compound

Structure

InChIKeySETFNECMODOHTO-UHFFFAOYSA-NSMILESNS(=O)(=O)C1=CC=C(C=C1)S(=O)(=O)NC1=CC=CC2=C1NC=C2Cl

Targets

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1,212Drug interactionsStructured to mechanism, not free text

9Clinical trialsPhase, status and sponsor resolved per trial

12+ReferencesStructured and connected to the statements they support

Which drugs share a target with Indisulam, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.